Valuation: Becton, Dickinson and Company

Market Cap 49.21B 1,654B 43.69B 40.88B 37.05B 69.98B 4,744B 70.49B 491B 191B 2,420B 185B 181B 7,780B P/E 2026 *
34.8x
P/E 2027 * 19.4x
Enterprise Value 65.1B 2,188B 57.79B 54.08B 49.02B 92.57B 6,275B 93.24B 649B 253B 3,201B 244B 239B 10,291B EV / Sales 2026 *
3.38x
EV / Sales 2027 * 3.2x
Free-Float
73.18%
Yield 2026 *
2.17%
Yield 2027 * 2.21%
1 day+3.52%
Current month+0.98%
1 month+0.98%
3 months+19.08%
6 months+21.89%
Current year+1.98%
1 week 1.97
Extreme 1.97
2.06
1 month 1.93
Extreme 1.93
2.14
Current year 1.54
Extreme 1.54
2.36
1 year 1.54
Extreme 1.54
2.36
3 years 1.54
Extreme 1.54
2.36
5 years 1.54
Extreme 1.54
2.36
10 years 1.54
Extreme 1.54
2.36
Manager TitleAgeSince
Chief Executive Officer 53 27/01/2020
Director of Finance/CFO 44 04/12/2025
Chief Tech/Sci/R&D Officer 56 03/12/2023
Director TitleAgeSince
Director/Board Member 75 23/09/2002
Director/Board Member 71 25/07/2010
Chairman 53 27/04/2021
Change 5-day change 1-year change 3-year change Capi.($)
+3.52%0.00% - - 49.21B
-1.46%-2.12%-26.12%+1.99% 173B
-1.23%-0.09%-11.60%+14.31% 113B
-1.91%+0.25%-23.70%+5.12% 109B
+1.52%+1.45%-46.87%-10.58% 74.44B
-0.38%+1.77%+2.54%+70.27% 60.1B
+3.27%+7.25%+18.14%+67.16% 51.87B
+0.11%-0.76%-5.94%-31.18% 49.21B
-1.99%-3.04%-17.61%+15.98% 41.52B
-3.61%-3.27%+26.29%+0.70% 32.79B
Average -0.22%+0.62%-9.43%+14.86% 78.34B
Weighted average by Cap. -0.49%+0.42%-15.57%+12.18%

Financials

2026 *2027 *
Net sales 19.28B 648B 17.11B 16.01B 14.51B 27.41B 1,858B 27.61B 192B 74.81B 948B 72.36B 70.81B 3,047B 19.74B 663B 17.52B 16.4B 14.86B 28.07B 1,903B 28.27B 197B 76.6B 971B 74.09B 72.5B 3,120B
Net income 1.44B 48.28B 1.28B 1.19B 1.08B 2.04B 138B 2.06B 14.33B 5.57B 70.65B 5.39B 5.28B 227B 2.34B 78.62B 2.08B 1.94B 1.76B 3.33B 226B 3.35B 23.34B 9.08B 115B 8.78B 8.59B 370B
Net Debt 15.88B 534B 14.1B 13.2B 11.96B 22.59B 1,531B 22.75B 158B 61.64B 781B 59.63B 58.35B 2,511B 13.95B 469B 12.38B 11.59B 10.5B 19.84B 1,345B 19.98B 139B 54.14B 686B 52.37B 51.25B 2,206B
Projected Income Statement - Annual - Becton, Dickinson and Company
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
05/10/26 THB 2.060 +3.52% 26,991
05/10/26 THB 1.990 -2.45% 59,402
02/10/26 THB 2.040 -0.97% 1,451
01/10/26 THB 2.060 +0.98% 14,944
30/09/26 THB 2.040 -0.97% 29,957
Trader
Investor
Global
Quality
ESG MSCI
-
Ratings Surperformance© - Becton, Dickinson and Company
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
180.67USD
Average target price
196.50USD
Spread / Average Target
+8.76%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Becton, Dickinson and Company